PAI recently completed the sale of ELITech Group, a global manufacturer of in-vitro diagnostics, to Bruker, a prominent international life science research and diagnostics solutions provider. The sale marked the culmination of a partnership that yielded significant value and is a testament to what PAI and ELITech achieved together during the period of ownership.

In this short video, Stefano Drago, Partner at PAI, and Christoph Gauer, CEO of ELITech, discuss the company’s transformation, including its notable financial growth and trajectory of innovation and leadership.